Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Itacitinib in Advanced Hepatocellular Carcinoma (JAKaL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04358185
Recruitment Status : Recruiting
First Posted : April 24, 2020
Last Update Posted : July 15, 2022
Incyte Biosciences UK Ltd
Information provided by (Responsible Party):
Imperial College London

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : December 31, 2022